Spero Therapeutics, Inc. (SPRO) Earnings
NASDAQ·Healthcare·Biotechnology
$2.69
+0.56%
Mkt Cap $130.71M
Next Earnings
In 12 daysMon, May 11, 2026
EPS Estimate
-$0.17
1 analysts
Revenue Estimate
$47.36M
Last quarter: beat by +365.00% on EPS, +58.83% on revenue.
EPS — Estimate vs Actual
Mkt Cap
$130.71M
P/E
—
Fwd P/E
3.63
P/S
2.56
Rev TTM
—
EPS TTM
$0.15